H Stewart Parker - Net Worth and Insider Trading
H Stewart Parker Net Worth
The estimated net worth of H Stewart Parker is at least $131,738 dollars as of 2024-11-13. H Stewart Parker is the Director of Sangamo Therapeutics Inc and owns about 48,700 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $131,734. H Stewart Parker is also the Director of Achieve Life Sciences Inc and owns about 1 shares of Achieve Life Sciences Inc (ACHV) stock worth over $5. Details can be seen in H Stewart Parker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that H Stewart Parker has not made any transactions after 2022-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of H Stewart Parker
H Stewart Parker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H Stewart Parker owns 5 companies in total, including Sangamo Therapeutics Inc (SGMO) , Achieve Life Sciences Inc (ACHV) , and Armata Pharmaceuticals Inc (ARMP) among others .
Click here to see the complete history of H Stewart Parker’s form 4 insider trades.
Insider Ownership Summary of H Stewart Parker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2022-06-01 | director |
| ACHV | Achieve Life Sciences Inc | 2011-08-09 | director |
| ARMP | Armata Pharmaceuticals Inc | 2019-05-09 | director |
 | | 2021-04-22 | director |
| | 2022-12-16 | director |
H Stewart Parker Latest Holdings Summary
H Stewart Parker currently owns a total of 2 stocks. Among these stocks, H Stewart Parker owns 48,700 shares of Sangamo Therapeutics Inc (SGMO) as of June 1, 2022, with a value of $131,734 and a weighting of 100%. H Stewart Parker also owns 1 shares of Achieve Life Sciences Inc (ACHV) as of August 9, 2011, with a value of $5 and a weighting of 0%.
Latest Holdings of H Stewart Parker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2022-06-01 | 48,700 | 2.71 | 131,734 |
| ACHV | Achieve Life Sciences Inc | 2011-08-09 | 1 | 4.65 | 5 |
Holding Weightings of H Stewart Parker
H Stewart Parker Form 4 Trading Tracker
According to the SEC Form 4 filings, H Stewart Parker has made a total of 2 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sangamo Therapeutics Inc is the acquisition of 5,000 shares on June 1, 2022, which cost H Stewart Parker around $18,000.
According to the SEC Form 4 filings, H Stewart Parker has made a total of 0 transactions in Achieve Life Sciences Inc (ACHV) over the past 5 years. The most-recent trade in Achieve Life Sciences Inc is the acquisition of 1 shares on August 9, 2011, which cost H Stewart Parker around $30,270.
Insider Trading History of H Stewart Parker
- 1
H Stewart Parker Trading Performance
GuruFocus tracks the stock performance after each of H Stewart Parker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H Stewart Parker is 22.17%. GuruFocus also compares H Stewart Parker's trading performance to market benchmark return within the same time period. The performance of stocks bought by H Stewart Parker within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how H Stewart Parker's insider trading performs compared to the benchmark.
Performance of H Stewart Parker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.04 | | | | | |
| Relative Return to S&P 500(%) | 13.38 | | | | | |
H Stewart Parker Ownership Network
Ownership Network List of H Stewart Parker
Ownership Network Relation of H Stewart Parker
H Stewart Parker Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
H Stewart Parker is the director of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, H Stewart Parker made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
H Stewart Parker Mailing Address
Above is the net worth, insider trading, and ownership report for H Stewart Parker. Currently GuruFocus does not have mailing address information for H Stewart Parker.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
